Express News | Calidi Biotherapeutics Shares Are Trading Higher After the Company Announced It Presented Data at the International Oncolytic Virotherapy Conference and the Society for Immunotherapy of Cancer Annual Meeting

BenzingaNov 18 13:11 ET

Calidi Biotherapeutics Reveals Promising Virotherapy Data

TipRanksNov 18 08:29 ET

Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer

GlobeNewswireNov 18 08:00 ET

Calidi Biotherapeutics: Innovative Cancer Treatment With Promising Clinical Results but Financial Challenges

TipRanksNov 18 05:06 ET

NYSE American Net Change Percentage Gainers & Losers

Dow JonesNov 15 17:41 ET

Calidi Biotherapeutics Inc. Completes Public Offering, Raising Approximately $7.5 Million

Quiver QuantitativeNov 15 16:11 ET